看看查看全文
来源:格隆汇 格隆汇6月14日丨Agile Therapeutics(AGRX.US)盘前涨35.65%,报4.87美元。Agile Therapeutics宣布与VitaCare处方服务公司达成新协议,以扩大Twirla的使用范围,推动公司2023年实现净收入2500万至30... 网页链接
$Agile Therapeutics(AGRX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-16 AccNo: 0000902664-16-005754 Size: 115 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-02-04 AccNo: 0001104659-16-093968 Size: 33 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-01 AccNo: 0001193125-16-446191 Size: 42 KB 网页链接
$Agile Therapeutics(AGRX)$ 内部交易: 2016-01-27,10% Owner,Moorin Jay ,买入,393700普通股, $6.35
$Agile Therapeutics(AGRX)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2016-01-29 AccNo: 0000932440-16-000308 Size: 144 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-01-25 AccNo: 0001104659-16-091210 Size: 316 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-01-22 AccNo: 0001047469-16-009803 Size: 636 KB 网页链接
$Agile Therapeutics(AGRX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-01-21 AccNo: 0001047469-16-009770 Size: 640 KB 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2016-01-11 AccNo: 0001104659-16-088999 Size: 3 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Agile Therapeutics(AGRX)$ 8-K - Current report Filed: 2015-12-01 AccNo: 0001104659-15-082094 Size: 36 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接